How long does it usually take to take Mobotinib?

Mobosetinib is a targeted therapy for locally advanced or metastatic non-small cell lung cancer (NSCLC) that has an insertion mutation in exon 20 of the epidermal growth factor receptor (EGFR). Regarding the question of how long Mobotinib usually needs to be taken, it actually depends on a number of factors, including the patient's specific condition, response to treatment, and the doctor's guidance.

The recommended dose of mobotinib is 160 mg once daily, which is equivalent to taking 4 pills per day (40 mg per pill). Patients should continue taking mobotinib until disease progression or unacceptable toxicity occurs.

There is no fixed length of treatment for Mobotinib. Effects and duration of treatment vary from person to person and depend on the tumor's response to the drug and the patient's overall health. According to clinical trial data, Mobotinib can significantly shrink or eliminate tumors in some patients (about 28%), and the effective duration can reach 17.5 months, and the average patient overall survival time is 24 months.

During treatment, if adverse reactions occur, your doctor may adjust the dose or temporarily discontinue the medication. Common dosage adjustments include reductions to 120 mg (3 pills) or 80 mg (2 pills) per day. In the case of certain serious adverse reactions, such as QTc interval prolongation, interstitial lung disease, heart failure, etc., the doctor may decide to permanently discontinue the drug.

The price of mobotinib varies by brand and source. For example, Japan's Takeda Pharmaceutical's version is more expensive, while generic versions such as Laos' Lucius version are relatively cheaper. Patients need to choose the appropriate source of medication based on their financial situation and the advice of their doctor.